Addiction and Harm Reduction

Selected Books and Book Chapters:

1. Stein M (1996). "Medical Disorders in Addicted Patients (Chapter)." In: Miller N (Ed.), Addiction Psychiatry: A Comprehensive Textbook. Philadelphia, W.B. Saunders Co.

2. Holmes L, Mitty J, Flanigan T (2003). "Project Bridge; Combining Case Management with Peer Support (Chapter)." In: Altice F, Selwyn PA, et al. (Ed.), Reaching In, Reaching Out: Treating HIV/AIDS in the Correctional Community. Chicago, National Commission on Correctional Healthcare (NCCHC): 209-223.

3. Libman H, Stein M (2003). "Primary Care and Prevention of HIV Disease (Chapter)." In: Libman H, Makadon H (Ed.), HIV, Third Edition. American College of Physicians -- American Society of Internal Medicine: 39-76.

4. Stein M (2005). "Alcohol and Substance Abuse (Chapter 14)." In: Goldberg R (Ed.), Practical Guide to the Care of the Psychiatric Patient, 3rd Edition. Philadelphia, Elsevier Academic Press.

5. Taylor L, Schwartzapfel B, Gholam PM (2006). "Limiting Harm from Chronic Hepatitis C Infection for HIV-Positive People with Drug Dependency: Prevention and Treatment." In: Pizer HF, Mayer K (Ed.), Delivering HIV Care and Treatment for People Who Use Drugs: Lessons from Research and Practice. New York, N.Y., Open Society Institute: 95-109.

6. Greifinger R, Lincoln T, Clear T, et al. (2007). "Screening for Public Purpose: Promoting an Evidence-based Approach to Screening of Inmates to Improve Public Health (Chapter)." In: Greifinger R (Ed.), Public Health Behind Bars: From Prisons to Communities. New York, Springer Publishing.

7. Nijhawan A, Zaller N, Cohen D, et al. (2008). "Interventions with Incarcerated Persons (Chapter)." In: Pizer HF, Mayer K (Ed.), HIV Prevention. San Diego, Elsevier Academic Press.

Peer-Reviewed Publications:

1. Carpenter CC, Mayer KH, Stein MD, et al. (1991). "Human immunodeficiency virus infection in North American women: experience with 200 cases and a review of the literature." Medicine (Baltimore) 70(5):307-325.

2. Stein MD, Piette J, Mor V, et al. (1991). "Differences in access to zidovudine (AZT) among symptomatic HIV-infected persons." J Gen Intern Med 6(1):35-40.

3. Stein MD, O'Sullivan PS, Ellis P, et al. (1993). "Utilization of medical services by drug abusers in detoxification." J Subst Abuse 5(2):187-193.

4. Stein MD, Samet JH, O'Connor PG. (1993). "The linkage of primary care services with substance abuse treatment: new opportunities for academic generalists." J Gen Intern Med 8(2):106-107.

5. Hoy JF, Flanigan TP. (1994). "Wasting associated with cocaine and heroin use in patients infected with human immunodeficiency virus." Clin Infect Dis 19(1):209-210.

6. Flanigan TP, Uvin SC, Rich JD, et al. (1996). "Update of HIV and AIDS in North America." Med Health R I 79(5):180-187.

7. Lewis DC, Rich JD. (1996). "Physicians should support needle exchange in Rhode Island." Med Health R I 79(6):206.

8. Farrar DJ, Flanigan TP, Gordon NM, et al. (1997). "Tuberculous brain abscess in a patient with HIV infection: case report and review." Am J Med 102(3):297-301.

9. Stein MD, Cyr MG. (1997). "Women and substance abuse." Med Clin North Am 81(4):979-998.

10. Stein MD, Hanna L. (1997). "Use of mental health services by HIV-infected women." J Womens Health 6(5):569-574.

11. Mylonakis E, Koutkia P, Rich JD, et al. (1998). "Substance abuse is responsible for most pre-AIDS deaths among women with HIV infection in Providence, Rhode Island, USA." AIDS 12(8):958-959.

12. Rich JD, Dickinson BP, Carney JM, et al. (1998). "Detection of HIV-1 nucleic acid and HIV-1 antibodies in needles and syringes used for non-intravenous injection." AIDS 12(17):2345-2350.

13. Rich JD, Dickinson BP, Liu KL, et al. (1998). "Strict syringe laws in Rhode Island are associated with high rates of reusing syringes and HIV risks among injection drug users." J Acquir Immune Defic Syndr Hum Retrovirol 18 Suppl 1:S140-141.

14. Rich JD, Dickinson BP, Merriman NA, et al. (1998). "Hepatitis C virus infection related to anabolic-androgenic steroid injection in a recreational weight lifter." Am J Gastroenterol 93(9):1598.

15. Rich JD, Dickinson BP, Spaulding A, et al. (1998). "Interpretation of indeterminate HIV serology results in an incarcerated population." J Acquir Immune Defic Syndr Hum Retrovirol 17(4):376-379.

16. Rich JD, Dokson L, Dickinson BP. (1998). "The economic cost of strict syringe control." Med Health R I 81(6):207-208.

17. Stein MD, Freedberg KA, Sullivan LM, et al. (1998). "Sexual ethics. Disclosure of HIV-positive status to partners." Arch Intern Med 158(3):253-257.

18. Stein MD, Mulvey KP, Plough A, et al. (1998). "The functioning and well being of persons who seek treatment for drug and alcohol use." J Subst Abuse 10(1):75-84.

19. Clarke J, Stein MD, Sobota M, et al. (1999). "Victims as victimizers: physical aggression by persons with a history of childhood abuse." Arch Intern Med 159(16):1920-1924.

20. Flanigan TP, Hogan JW, Smith D, et al. (1999). "Self-reported bacterial infections among women with or at risk for human immunodeficiency virus infection." Clin Infect Dis 29(3):608-612.

21. Rich JD, Dickinson BP, Feller A, et al. (1999). "The infectious complications of anabolic-androgenic steroid injection." Int J Sports Med 20(8):563-566.

22. Rich JD, Dickinson BP, Flanigan TP, et al. (1999). "Abscess related to anabolic-androgenic steroid injection." Med Sci Sports Exerc 31(2):207-209.

23. Rich JD, Dickinson BP, Macalino G, et al. (1999). "Prevalence and incidence of HIV among incarcerated and reincarcerated women in Rhode Island." J Acquir Immune Defic Syndr 22(2):161-166.

24. Rich JD, Foisie CK, Towe CW, et al. (1999). "Needle exchange program participation by anabolic steroid injectors, United States 1998." Drug Alcohol Depend 56(2):157-160.

25. Rich JD, Strong L, Towe CW, et al. (1999). "Obstacles to needle exchange participation in Rhode Island." J Acquir Immune Defic Syndr 21(5):396-400.

26. Stein MD. (1999). "Medical consequences of substance abuse." Psychiatr Clin North Am 22(2):351-370.

27. Willy RJ, Salas CM, Macalino GE, et al. (1999). "Long-term non-progression of HIV-1 in a patient coinfected with HTLV-II." Diagn Microbiol Infect Dis 35(4):269-270.

28. Burris S, Lurie P, Abrahamson D, et al. (2000). "Physician prescribing of sterile injection equipment to prevent HIV infection: time for action." Ann Intern Med 133(3):218-226.

29. Clarke JG, Cyr MG, Spaulding A. (2000). "Prisons: learning about women's health and substance abuse." Acad Med 75(5):544.

30. Farley JL, Mitty JA, Lally MA, et al. (2000). "Comprehensive medical care among HIV-positive incarcerated women: the Rhode Island experience." J Womens Health Gend Based Med 9(1):51-56.

31. Rich JD, Foisie CK, Towe CW, et al. (2000). "High street prices of syringes correlate with strict syringe possession laws." Am J Drug Alcohol Abuse 26(3):481-487.

32. Rich JD, Strong LL, Mehrotra M, et al. (2000). "Strategies to optimize the impact of needle exchange programs." AIDS Read 10(7):421-429.

33. Stein MD, Rich JD, Maksad J, et al. (2000). "Adherence to antiretroviral therapy among HIV-infected methadone patients: effect of ongoing illicit drug use." Am J Drug Alcohol Abuse 26(2):195-205.

34. Stein MD, Urdaneta ME, Clarke J, et al. (2000). "Use of antiretroviral therapies by HIV-infected persons receiving methadone maintenance." J Addict Dis 19(1):85-94.

35. Cannon MJ, Dollard SC, Smith DK, et al. (2001). "Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection." N Engl J Med 344(9):637-643.

36. Clarke JG, Stein MD, Hanna L, et al. (2001). "Active and Former Injection Drug Users Report of HIV Risk Behaviors During Periods of Incarceration." Subst Abus 22(4):209-216.

37. Clarke JG, Stein MD, McGarry KA, et al. (2001). "Interest in smoking cessation among injection drug users." Am J Addict 10(2):159-166.

38. Cohen RA, Boland R, Paul R, et al. (2001). "Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women." AIDS 15(3):341-345.

39. Friedmann PD, Lemon SC, Stein MD. (2001). "Transportation and retention in outpatient drug abuse treatment programs." J Subst Abuse Treat 21(2):97-103.

40. Friedmann PD, Lemon SC, Stein MD, et al. (2001). "Linkage to medical services in the Drug Abuse Treatment Outcome Study." Med Care 39(3):284-295.

41. Friedmann PD, Saitz R, Gogineni A, et al. (2001). "Validation of the screening strategy in the NIAAA "Physicians' Guide to Helping Patients with Alcohol Problems"." J Stud Alcohol 62(2):234-238.

42. Pugatch D, Levesque B, Greene S, et al. (2001). "HIV testing in the setting of inpatient acute substance abuse treatment." Am J Drug Alcohol Abuse 27(3):491-499.

43. Pugatch D, Strong LL, Has P, et al. (2001). "Heroin use in adolescents and young adults admitted for drug detoxification." J Subst Abuse 13(3):337-346.

44. Pugatch DL, Levesque BG, Lally MA, et al. (2001). "HIV testing among young adults and older adolescents in the setting of acute substance abuse treatment." J Acquir Immune Defic Syndr 27(2):135-142.

45. Rich JD, Holmes L, Salas C, et al. (2001). "Successful linkage of medical care and community services for HIV-positive offenders being released from prison." J Urban Health 78(2):279-289.

46. Rich JD, Macalino GE, McKenzie M, et al. (2001). "Syringe prescription to prevent HIV infection in Rhode Island: a case study." Am J Public Health 91(5):699-700.

47. Rich JD, McKenzie M, Macalino G, et al. (2001). "The genesis of syringe prescription to prevent HIV in Rhode Island." Health Matrix Clevel 11(1):129-145.

48. Rich JD, Whitlock TL, Towe CW, et al. (2001). "Prescribing syringes to prevent HIV: a survey of infectious disease and addiction medicine physicians in Rhode Island." Subst Use Misuse 36(5):535-550.

49. Stein MD, Anderson B, Charuvastra A, et al. (2001). "Alcohol use and sexual risk taking among hazardously drinking drug injectors who attend needle exchange." Alcohol Clin Exp Res 25(10):1487-1493.

50. Stein MD, Friedmann PD. (2001). "Generalist physicians and addiction care: from turfing to sharing the turf." JAMA 286(14):1764-1765.

51. Stein MD, Maksad J, Clarke J. (2001). "Hepatitis C disease among injection drug users: knowledge, perceived risk and willingness to receive treatment." Drug Alcohol Depend 61(3):211-215.

52. Stein MD, Sobota M. (2001). "Injection drug users: hospital care and charges." Drug Alcohol Depend 64(1):117-120.

53. Tashima KT, Hogan JW, Gardner LI, et al. (2001). "A longitudinal analysis of hospitalization and emergency department use among human immunodeficiency virus-infected women reporting protease inhibitor use." Clin Infect Dis 33(12):2055-2060.

54. Thomas DL, Rich JD, Schuman P, et al. (2001). "Multicenter evaluation of hepatitis C RNA levels among female injection drug users." J Infect Dis 183(6):973-976.

55. Desai AA, Latta ET, Spaulding A, et al. (2002). "The importance of routine HIV testing in the incarcerated population: the Rhode Island experience." AIDS Educ Prev 14(5 Suppl B):45-52.

56. Lally MA, Alvarez S, Macnevin R, et al. (2002). "Acceptability of sexually transmitted infection screening among women in short-term substance abuse treatment." Sex Transm Dis 29(12):752-755.

57. Rich JD, Martin EG, Macalino GE, et al. (2002). "Pharmacist support for selling syringes without a prescription to injection drug users in Rhode Island." J Am Pharm Assoc (Wash) 42(6 Suppl 2):S58-61.

58. Rich JD, Wolf FA, Macalino G. (2002). "Strategies to improve access to sterile syringes for injection drug users." AIDS Read 12(12):527-535.

59. Stein MD, Anderson B, Charuvastra A, et al. (2002). "A brief intervention for hazardous drinkers in a needle exchange program." J Subst Abuse Treat 22(1):23-31.

60. Stein MD, Charuvastra A, Anderson B, et al. (2002). "Alcohol and HIV risk taking among intravenous drug users." Addict Behav 27(5):727-736.

61. Stein MD, Charuvastra A, Anderson BJ. (2002). "Social support and zero sharing risk among hazardously drinking injection drug users." J Subst Abuse Treat 23(3):225-230.

62. Stein MD, Friedmann P. (2002). "Need for medical and psychosocial services among injection drug users: a comparative study of needle exchange and methadone maintenance." Am J Addict 11(4):262-270.

63. Allen SA, Spaulding AC, Osei AM, et al. (2003). "Treatment of chronic hepatitis C in a state correctional facility." Ann Intern Med 138(3):187-190.

64. Friedmann PD, Herman DS, Freedman S, et al. (2003). "Treatment of sleep disturbance in alcohol recovery: a national survey of addiction medicine physicians." J Addict Dis 22(2):91-103.

65. Friedmann PD, Lemon SC, Anderson BJ, et al. (2003). "Predictors of follow-up health status in the Drug Abuse Treatment Outcome Study (DATOS)." Drug Alcohol Depend 69(3):243-251.

66. Friedmann PD, Lemon SC, Stein MD, et al. (2003). "Community referral sources and entry of treatment-naive clients into outpatient addiction treatment." Am J Drug Alcohol Abuse 29(1):105-115.

67. Friedmann PD, Lemon SC, Stein MD, et al. (2003). "Accessibility of addiction treatment: results from a national survey of outpatient substance abuse treatment organizations." Health Serv Res 38(3):887-903.

68. Friedmann PD, Zhang Z, Hendrickson J, et al. (2003). "Effect of primary medical care on addiction and medical severity in substance abuse treatment programs." J Gen Intern Med 18(1):1-8.

69. Harwell JI, Flanigan TP, Mitty JA, et al. (2003). "Directly observed antiretroviral therapy to reduce genital tract and plasma HIV-1 RNA in women with poor adherence." AIDS 17(13):1990-1993.

70. Macalino GE, Ko H, Celentano DD, et al. (2003). "Drug use patterns over time among HIV-seropositive and HIV-seronegative women: the HER study experience." J Acquir Immune Defic Syndr 33(4):500-505.

71. Rich JD, Taylor L, Mehrotra M, et al. (2003). "Prescribing syringes to injection drug users: what the family physician should know." Am Fam Physician 68(1):45-47.

72. Stancliff S, Agins B, Rich JD, et al. (2003). "Syringe access for the prevention of blood borne infections among injection drug users." BMC Public Health 3:37.

73. Stein MD, Anderson B. (2003). "Injection frequency mediates health service use among persons with a history of drug injection." Drug Alcohol Depend 70(2):159-168.

74. Stein MD, Anderson BJ. (2003). "Nicotine and drug interaction expectancies among methadone maintained cigarette smokers." J Subst Abuse Treat 24(4):357-361.

75. Stein MD, Solomon DA, Herman DS, et al. (2003). "Depression severity and drug injection HIV risk behaviors." Am J Psychiatry 160(9):1659-1662.

76. Taylor LE, Runarsdottir V, Zampi A, et al. (2003). "Would you consider prescribing syringes to injection drug users? Addiction Medicine Conference Survey." J Addict Dis 22(1):67-78.

77. Boutwell A, Rich JD. (2004). "Syringe access for injection drug users in Rhode Island." Med Health R I 87(1):15-16.

78. Macalino GE, Vlahov D, Sanford-Colby S, et al. (2004). "Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons." Am J Public Health 94(7):1218-1223.

79. Rich JD, McKenzie M, Macalino GE, et al. (2004). "A syringe prescription program to prevent infectious disease and improve health of injection drug users." J Urban Health 81(1):122-134.

80. Rompalo AM, Shah N, Margolick JB, et al. (2004). "Evaluation of possible effects of continued drug use on HIV progression among women." Int J STD AIDS 15(5):322-327.

81. Stein MD, Herman DS, Bishop S, et al. (2004). "Sleep disturbances among methadone maintained patients." J Subst Abuse Treat 26(3):175-180.

82. Stein MD, Herman DS, Solomon DA, et al. (2004). "Adherence to treatment of depression in active injection drug users: the minerva study." J Subst Abuse Treat 26(2):87-93.

83. Stein MD, Solomon DA, Herman DS, et al. (2004). "Pharmacotherapy plus psychotherapy for treatment of depression in active injection drug users." Arch Gen Psychiatry 61(2):152-159.

84. Stozek MA, Taylor LE, LeBreux L, et al. (2004). "Prescribing syringes to injection drug users with HIV: an important clinical and public health tool." J Assoc Nurses AIDS Care 15(2):59-63.

85. Vallabhaneni S, Macalino GE, Reinert SE, et al. (2004). "Prisoners' attitudes toward Hepatitis B vaccination." Prev Med 38(6):828-833.

86. Beckwith CG, Flanigan TP, del Rio C, et al. (2005). "It is time to implement routine, not risk-based, HIV testing." Clin Infect Dis 40(7):1037-1040.

87. Boutwell AE, Allen SA, Rich JD. (2005). "Opportunities to address the hepatitis C epidemic in the correctional setting." Clin Infect Dis 40 Suppl 5:S367-372.

88. Boutwell AE, Rich JD. (2005). "Arrested, addicted: heroin users in the Rhode Island Corrections System." Med Health R I 88(12):421-423.

89. Edlin BR, Kresina TF, Raymond DB, et al. (2005). "Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users." Clin Infect Dis 40 Suppl 5:S276-285.

90. Flanigan TP, Taylor LE, Mitty JA. (2005). "Use of community-based, directly observed therapy for HIV infection: lessons learned for treatment of hepatitis C virus infection." Clin Infect Dis 40 Suppl 5:S346-348.

91. Lally MA, MacNevin R, Sergie Z, et al. (2005). "A model to provide comprehensive testing for HIV, viral hepatitis, and sexually transmitted infections at a short-term drug treatment center." AIDS Patient Care STDS 19(5):298-305.

92. Macalino GE, Dhawan D, Rich JD. (2005). "A missed opportunity: hepatitis C screening of prisoners." Am J Public Health 95(10):1739-1740.

93. McKenzie M, Macalino G, McClung C, et al. (2005). "Opiate replacement therapy at time of release from incarceration: Project MOD, a pilot program." J Opioid Manag 1(3):147-151.

94. Rich JD, Boutwell AE, Shield DC, et al. (2005). "Attitudes and practices regarding the use of methadone in US state and federal prisons." J Urban Health 82(3):411-419.

95. Rich JD, McKenzie M, Shield DC, et al. (2005). "Linkage with methadone treatment upon release from incarceration: a promising opportunity." J Addict Dis 24(3):49-59.

96. Stein MD, Friedmann PD. (2005). "Disturbed sleep and its relationship to alcohol use." Subst Abus 26(1):1-13.

97. Stein MD, Solomon DA, Anderson BJ, et al. (2005). "Persistence of antidepressant treatment effects in a pharmacotherapy plus psychotherapy trial for active injection drug users." Am J Addict 14(4):346-357.

98. Stein MD, Weinstock MC, Herman DS, et al. (2005). "Respiratory symptom relief related to reduction in cigarette use." J Gen Intern Med 20(10):889-894.

99. Taylor LE. (2005). "Delivering care to injection drug users coinfected with HIV and hepatitis C virus." Clin Infect Dis 40 Suppl 5:S355-361.

100. Taylor LE, Gholam PM, Schwartzapfel B, et al. (2005). "Hepatitis C treatment in an HIV-HCV-coinfected patient with drug addiction and psychiatric illness: a case report." AIDS Read 15(11):629-631, 634-626, 638.

101. Zaller N, Noak A, Poshkus M, et al. (2005). "The overlapping epidemics of viral hepatitis/HIV, addiction and incarceration: the situation in Rhode Island." Med Health R I 88(12):424-427.

102. Beckwith CG, Moreira CC, Aboshady HM, et al. (2006). "A success story: HIV prevention for injection drug users in Rhode Island." Subst Abuse Treat Prev Policy 1:34.

103. Clarke JG, Rosengard C, Rose J, et al. (2006). "Pregnancy attitudes and contraceptive plans among women entering jail." Women Health 43(2):111-130.

104. Flanigan TP, Mitty JA. (2006). "The good, the bad, and the ugly: providing highly active antiretroviral therapy when it is most difficult." Clin Infect Dis 42(11):1636-1638.

105. Friedmann PD, Hendrickson JC, Gerstein DR, et al. (2006). "Do mechanisms that link addiction treatment patients to primary care influence subsequent utilization of emergency and hospital care?" Med Care 44(1):8-15.

106. Pugatch D, Anderson BJ, O'Connell JV, et al. (2006). "HIV and HCV testing for young drug users in Rhode Island." J Adolesc Health 38(3):302-304.

107. Rich JD, Anderson BJ, Schwartzapfel B, et al. (2006). "Sexual risk for hepatitis B virus infection among hepatitis C virus-negative heroin and cocaine users." Epidemiol Infect 134(3):478-484.

108. Stein MD, Anderson BJ, Lassor J, et al. (2006). "Receipt of disability payments by substance users: mental and physical health correlates." Am J Addict 15(2):160-165.

109. Stein MD, Anderson BJ, Niaura R. (2006). "Nicotine replacement therapy: patterns of use after a quit attempt among methadone-maintained smokers." J Gen Intern Med 21(7):753-757.

110. Stein MD, Weinstock MC, Herman DS, et al. (2006). "A smoking cessation intervention for the methadone-maintained." Addiction 101(4):599-607.

111. Zaller ND, Thurmond P, Brett J, et al. (2006). "Linkage to methadone treatment from acute opiate detoxification treatment." J Opioid Manag 2(6):341-346.

112. Beckwith CG, Zaller N, Flanigan TP. (2007). "HIV counseling and testing among injection drug users needs to continue." Am J Public Health 97(7):1161.

113. Beletsky L, Ruthazer R, Macalino GE, et al. (2007). "Physicians' knowledge of and willingness to prescribe naloxone to reverse accidental opiate overdose: challenges and opportunities." J Urban Health 84(1):126-136.

114. Brim N, Zaller N, Taylor LE, et al. (2007). "Twinrix vaccination schedules among injecting drug users." Expert Opin Biol Ther 7(3):379-389.

115. McKenzie M, Rich JD. (2007). "Heroin in the corrections system: introduction." Med Health R I 90(5):140-141.

116. Rich JD, Hogan JW, Wolf F, et al. (2007). "Lower syringe sharing and re-use after syringe legalization in Rhode Island." Drug Alcohol Depend 89(2-3):292-297.

117. Schwartz RP, McKenzie M, Rich JD. (2007). "Opioid addiction and incarceration: an overview." Med Health R I 90(5):157-158.

118. Stein MD, Dubyak P, Herman D, et al. (2007). "Perceived barriers to safe-injection practices among drug injectors who remain HCV-negative." Am J Drug Alcohol Abuse 33(4):517-525.

119. Stein MD, Weinstock MC, Anderson BJ, et al. (2007). "Relationship of depression to smoking outcomes in a methadone-maintained population." J Addict Dis 26(1):35-40.

120. Zaller N. (2007). "Drug court as an alternative to incarceration." Med Health R I 90(5):154-156.